Marc Ullman was cited in the NutraIngredientsUSA.com article, “FDA takes Quicksilver Scientific to task over alleged disease claims in blog post.”

The article examines how narrow the margin between acceptable language and an alleged disease claim can be. Dietary supplement manufacturer, Quicksilver Scientific, made a number of alleged disease claims in blog posts that earned

Steven Shapiro was interviewed by HBW Insight for the article, “P&G Wraps Launch Of Super C Supplement Brand In Co-Packaging With DayQuil And NyQuil OTCs.”

The story describes how Procter & Gamble may have exploited an ambiguity in the Food & Drug Administration’s policy when packaging its Super C supplement brand with DayQuil and Nyquil. The

Marc Ullman was quoted in the NutraIngredientsUSA.com article, “Cohen-led team concludes phenibut warnings had no deterrent effect.”

The article explains how Dr. Pieter Cohen’s team did research on dietary supplements that contained phenibut in 2017, and found that not only did the companies continue using the ingredient in 2019 after being issued warning letters from

Marc Ullman was interviewed for the Nutraingredients-USA article, “Synthetic glycans developer issued warning over failure to file IND in COVID-19 trials.”

The Food & Drug Administration (FDA) issued a warning letter to Kaleido for the way they set up trials for its synthetic glycans product. The FDA’s position was that the trials were attempting to

The prestigious Best Lawyers in America has again included Rivkin Radler LLP in its U.S. rankings for 2022. For the first time, the firm was recognized in the areas of tax and technology.

One Rivkin attorney, based in Albany, has been named Lawyer of the Year: Richard A. Frankel, for Trusts and Estates.

In addition,

Steven Shapiro participated in a webinar hosted by Informa Markets, entitled “Short Legal Briefs with Josh Long.”

The webinar presented the case against amending the Federal Food Drug and Cosmetic Act to require companies to submit all dietary supplement product labels to the Food and Drug Administration.

“Short Legal Briefs with Josh Long,” describes itself

Please join us as Rivkin Radler partners Christopher J. Kutner and John Queenan present how to think through information requests to construct the proper response.

Program overview:

• State and federal agency requests
• Payor requests (Medicare, Medicaid, and commercial)
• Disclosure rules based on the types of records involved
•

Marc Ullman was quoted in the NutraIngredients-USA.com article, “Experts offer clarity on labeling calories for non-macronutrients.”

The article focuses on the citizen’s petition filed by the Natural Products Association regarding the labeling of calories from branched chain amino acids.

Ullman explained that there are some issues with the regulation. “There’s no way to put these

Marc Ullman commented in the NutraIngredients-USA.com article, “FTC finalizes ‘Made in the USA’ rule.”

According to the article, the Federal Trade Commission has issued its final ‘Made in the USA’ rule about how companies can make this claim on their packaging and in advertising.

In regards to dietary supplements, “Made in the USA claims continue

Marc Ullman was quoted in the NutraIngredients-USA article, “FDA lists NDI update among priorities for coming year.”

The article discusses a list of priorities released yesterday by the US Food and Drug Administration (FDA), which included New Dietary Ingredients (NDI) Draft Guidance.

“FDA’s entire handling of NDIs has been absurd,” Ullman said. “It seems to